NMO

(redirected from neuromyelitis optica)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
NMONeuromyelitis Optica
NMONursing and Midwifery Order (UK)
NMONormal Moveout
NMONetwork Management Option
NMONetwork Mode of Operation
NMONetwork Management Office
NMONormal Manual Operation
NMONederlandse Moslim Omroep (Dutch: Dutch Muslim Broadcasting)
NMONew Motorola (antenna mounting)
NMONational Member Organisation
NMONASA Management Office (JPL)
NMONetwork Maintenance Operative
NMONational Marketing Online (Florida)
NMONational Marketing Organization
NMONon-Magnetic Option (antenna)
NMONational Measurement Office (UK)
NMONetwork Mode of Operation (GSM)
NMONumber of Methods Overridden
NMOnonmachinable outside (US Postal Service; manually handled US postal mail)
NMONetwork Management Operations
NMONon-Molestation Order
NMONew Management Orientation
References in periodicals archive ?
This press release contains forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Alexion, including statements related to: the potential benefits of SOLIRIS as a treatment for adult patients with anti-aquaporin 4 (AQP4) antibody positive neuromyelitis optica spectrum disorder (NMOSD) and the potential impact of SOLIRIS on the NMOSD community; the ability of SOLIRIS to change the treatment paradigm for NMOSD and that SOLIRIS can provide benefits for patients with NMOSD.
Impact of eculizumab on reported quality of life in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the PREVENT study.
TM has a number of different causes including multiple sclerosis (MS), neuromyelitis optica, and in association with connective tissue diseases, such as systemic lupus erythematosus and Sjogren's syndrome.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Benjamin Greenberg, who leads the Conquer programs at UT Southwestern, including the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Conquer Program at Children's Medical Center Dallas.
As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS) and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG), and is also developing it for patients with neuromyelitis optica spectrum disorder (NMOSD).
Brain MRI showed abnormal signals along the bottom of the fourth ventricle which was typically seen in neuromyelitis optica (NMO) and in the cerebellum.
OKLAHOMA CITY Oklahoma Medical Research Foundation scientist Bob Axtell, Ph.D., has received a four-year grant from the National Institutes of Health to study a rare autoimmune disease called neuromyelitis optica, or NMO.
Inebilzumab is being evaluated for the treatment of neuromyelitis optica, a rare condition affecting the optic nerve and spinal cord and is in Phase II study.
It has been found that cetirizine - common allergy medication - is safe, well-tolerated, and may reduce relapses in patients with neuromyelitis optica (NMO).